drugset / Trial / NCT03616405
Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess efficacy of a 14-day sequential therapy for the rescue treatment of refractory Helicobacter pylori infection, and whether it is safe while maintaining an ideal eradication rates.
Timeline
- Start
- 2019-04-01
- Primary completion
- 2019-11-30
- Completion
- 2020-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | — |
| Subject | Furazolidone | Small molecule | 100 mg | — |
| Subject | Rabeprazole | Small molecule | 10 mg | — |
| Subject | Tetracycline | Unknown | 500 mg | — |
| Subject | colloidal bismuth pectin | Unknown | 200 mg | — |